Future Journal of Pharmaceutical Sciences

Table 4 Effect on STV, DTZ, and their combinations on perfusate biomarker levels in IRI

From: Evaluation of cardioprotection and bio-efficacy enhancement of stevioside and diltiazem in rats

Treatment	Perfusate level (U/L)
Treatment	ALT	AST
IRI control	17.08 ± 1.08	37.37 ± 1.23
DTZ	22.46 ± 0.88^**	51.39 ± 3.31^***
STV 100	18.25 ± 0.62^***	42.08 ± 3.13^***
STV 200	16.97 ± 0.99^***	30.12 ± 1.22^***
STV 100 + DTZ	9.37 ± 1.30^***ο	19.10 ± 1.15^***οοο
STV 200 + DTZ	32.19 ± 2.97	72.44 ± 3.27

Results are expressed as mean ± SEM, n = 8
^*P < 0.05
^**P < 0.01
^***P < 0.001 when compared to IRI control
^οP < 0.05
^οοοP < 0.001 when compared to DTZ

Back to article page